These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32469975)

  • 1. Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations.
    Maes T; Mascaró C; Rotllant D; Lufino MMP; Estiarte A; Guibourt N; Cavalcanti F; Griñan-Ferré C; Pallàs M; Nadal R; Armario A; Ferrer I; Ortega A; Valls N; Fyfe M; Martinell M; Castro Palomino JC; Buesa Arjol C
    PLoS One; 2020; 15(5):e0233468. PubMed ID: 32469975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat.
    Antonijoan RM; Ferrero-Cafiero JM; Coimbra J; Puntes M; Martínez-Colomer J; Arévalo MI; Mascaró C; Molinero C; Buesa C; Maes T
    CNS Drugs; 2021 Mar; 35(3):331-344. PubMed ID: 33755924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Vafidemstat in Experimental Autoimmune Encephalomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis.
    Cavalcanti F; Gonzalez-Rey E; Delgado M; Falo CP; Mestre L; Guaza C; O'Valle F; Lufino MMP; Xaus J; Mascaró C; Lunardi S; Sacilotto N; Dessanti P; Rotllant D; Navarro X; Herrando-Grabulosa M; Buesa C; Maes T
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.
    Maes T; Mascaró C; Tirapu I; Estiarte A; Ciceri F; Lunardi S; Guibourt N; Perdones A; Lufino MMP; Somervaille TCP; Wiseman DH; Duy C; Melnick A; Willekens C; Ortega A; Martinell M; Valls N; Kurz G; Fyfe M; Castro-Palomino JC; Buesa C
    Cancer Cell; 2018 Mar; 33(3):495-511.e12. PubMed ID: 29502954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epigenetically regulated PP1α expression by KDM1A may contribute to oxycodone conditioned place preference in mice.
    Li HX; Yang LY; Wan YX; Zhao YP; Liu YF; Wen KS; Yang JJ; Fan XY
    Biomed Pharmacother; 2024 Jul; 176():116931. PubMed ID: 38870630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprobe-based assays of histone lysine demethylase 1A target occupation enable
    Mascaró C; Ortega A; Carceller E; Ruiz Rodriguez R; Ciceri F; Lunardi S; Yu L; Hilbert M; Maes T
    J Biol Chem; 2019 May; 294(20):8311-8322. PubMed ID: 30804215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
    J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct pharmacological Akt activation rescues Alzheimer's disease like memory impairments and aberrant synaptic plasticity.
    Yi JH; Baek SJ; Heo S; Park HJ; Kwon H; Lee S; Jung J; Park SJ; Kim BC; Lee YC; Ryu JH; Kim DH
    Neuropharmacology; 2018 Jan; 128():282-292. PubMed ID: 29079294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy.
    Romo-Morales A; Aladowicz E; Blagg J; Gatz SA; Shipley JM
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27888. PubMed ID: 31207107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of LW-AFC on the Hippocampal Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.
    Wang J; Liu Y; Cheng X; Zhang X; Liu F; Liu G; Qiao S; Ni M; Zhou W; Zhang Y; Li F
    J Alzheimers Dis; 2017; 57(1):227-240. PubMed ID: 28222521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.
    Pajtler KW; Weingarten C; Thor T; Künkele A; Heukamp LC; Büttner R; Suzuki T; Miyata N; Grotzer M; Rieb A; Sprüssel A; Eggert A; Schramm A; Schulte JH
    Acta Neuropathol Commun; 2013 May; 1():19. PubMed ID: 24252778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.
    Woodling NS; Colas D; Wang Q; Minhas P; Panchal M; Liang X; Mhatre SD; Brown H; Ko N; Zagol-Ikapitte I; van der Hart M; Khroyan TV; Chuluun B; Priyam PG; Milne GL; Rassoulpour A; Boutaud O; Manning-Boğ AB; Heller HC; Andreasson KI
    Brain; 2016 Jul; 139(Pt 7):2063-81. PubMed ID: 27190010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications by inhibiting histone deacetylases reverse memory impairment in insulin resistance induced cognitive deficit in mice.
    Sharma S; Taliyan R
    Neuropharmacology; 2016 Jun; 105():285-297. PubMed ID: 26805421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effects of Hydrolyzed Chicken Extract (Probeptigen®/Cmi-168) on Memory Retention and Brain Oxidative Stress in Senescence-Accelerated Mice.
    Chou MY; Chen YJ; Lin LH; Nakao Y; Lim AL; Wang MF; Yong SM
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31408929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Deacetylase 2 Inhibition Attenuates Downregulation of Hippocampal Plasticity Gene Expression during Aging.
    Singh P; Thakur MK
    Mol Neurobiol; 2018 Mar; 55(3):2432-2442. PubMed ID: 28364391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of icariin on memory impairment and neurochemical deficits in senescence-accelerated mouse prone 8 (SAMP8) mice.
    He XL; Zhou WQ; Bi MG; Du GH
    Brain Res; 2010 Jun; 1334():73-83. PubMed ID: 20380820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease.
    Maes T; Mascaró C; Ortega A; Lunardi S; Ciceri F; Somervaille TC; Buesa C
    Epigenomics; 2015; 7(4):609-26. PubMed ID: 26111032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
    Harada K; Nakato K; Yarimizu J; Yamazaki M; Morita M; Takahashi S; Aota M; Saita K; Doihara H; Sato Y; Yamaji T; Ni K; Matsuoka N
    Eur J Pharmacol; 2012 Jun; 685(1-3):59-69. PubMed ID: 22542656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomerised lychee fruit-derived polyphenol attenuates cognitive impairment in senescence-accelerated mice and endoplasmic reticulum stress in neuronal cells.
    Sakurai T; Kitadate K; Nishioka H; Fujii H; Ogasawara J; Kizaki T; Sato S; Fujiwara T; Akagawa K; Izawa T; Ohno H
    Br J Nutr; 2013 Nov; 110(9):1549-58. PubMed ID: 23537529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.